يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Zahlten-Kuemeli, Anita"', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1
    Academic Journal
    Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.

    المؤلفون: Wainberg, Zev, Kang, Yoon-Koo, Lee, Keun-Wook, Qin, Shukui, Yamaguchi, Kensei, Kim, In-Ho, Saeed, Anwaar, Oh, Sang, Li, Jin, Turk, Haci, Teixeira, Alexandra, Hitre, Erika, Udrea, Adrian, Cardellino, Giovanni, Sanchez, Raquel, Zahlten-Kümeli, Anita, Taylor, Kate, Enzinger, Peter

    المصدر: Gastric Cancer, vol 27, iss 3

    مصطلحات موضوعية: Bemarituzumab, FGFR2b, Gastric cancer, Targeted therapy, mFOLFOX6, Humans, Stomach Neoplasms, Fluorouracil, Receptor, Fibroblast Growth Factor, Type 2, Adenocarcinoma, Esophagogastric Junction, Antineoplastic Combined Chemotherapy Protocols, Esophageal Neoplasms, Antibodies, Monoclonal, Humanized

    وصف الملف: application/pdf

    Relation: qt9gw863qk; https://escholarship.org/uc/item/9gw863qk; https://escholarship.org/content/qt9gw863qk/qt9gw863qk.pdf

    الاتاحة: https://escholarship.org/uc/item/9gw863qk
    https://escholarship.org/content/qt9gw863qk/qt9gw863qk.pdf
    https://doi.org/10.1007/s10120-024-01466-w

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial.

    المؤلفون: Rha, Sun Young, Zhang, Yanqiao, Elme, Anneli, Pazo Cid, Roberto, Alacacioglu, Ahmet, Ziogas, Dimitrios C., Shitara, Kohei, Ranceva, Anastasija, Nemecek, Radim, Santoro, Armando, Calderon, Carlos Alberto, Korphaisarn, Krittiya, Davis, Tracy, Zahlten-Kuemeli, Anita, Conn, Christopher, Tan, Mengyao, Honeycutt, Hayden, Wainberg, Zev A.

    المصدر: JCO Precision Oncology; 1/24/2025, Vol. 9, p1-10, 10p

    مصطلحات موضوعية: PROTEIN overexpression, FIBROBLAST growth factor 2, FIBROBLAST growth factor receptors, CLINICAL trials, ESOPHAGOGASTRIC junction


    أضف إلى المفضلة
  3. 3
    Periodical
    Once-Weekly Carfilzomib with Dexamethasone Demonstrated Promising Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma Regardless of Age and Prior Bortezomib Exposure

    المؤلفون: Berdeja, Jesus G., Rifkin, Robert M., Lyons, Roger, Yang, Hui, Zahlten-Kuemeli, Anita, Aggarwal, Sanjay K., Iskander, Karim, Berenson, James

    المصدر: Blood; December 2016, Vol. 128 Issue: 22 p2129-2129, 1p

    Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء